LOGIN  |  REGISTER
Astria Therapeutics

DarioHealth (NASDAQ: DRIO) Stock Quote

Last Trade: US$1.22 0.01 0.83
Volume: 3,917
5-Day Change: -15.86%
YTD Change: -29.07%
Market Cap: US$36.500M

Latest News From DarioHealth

Dario's leading behavior change solutions continue to win interest in the employer, payer and pharmaceutical markets NEW YORK , July 16, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the... Read More
New research confirms behavior change driven by Dario digital platform is sustainable for 12 month period and supports clinical results for members taking a GLP-1 Additional research demonstrates 31% of Dario members with Type 2 diabetes achieve results reflecting diabetes remission NEW YORK , June 25, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health... Read More
After two decades of successfully scaling multiple healthcare companies, Steven Nelson joins DarioHealth as Chief Commercial Officer to accelerate revenue growth across the health plans, employers and pharma channels NEW YORK , June 5, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario", "DarioHealth" or the "Company"), a leader in the global digital health market, announced today a strategic reorganization... Read More
First quarter revenue of $5.8 million reflects an increase of 59% over fourth quarter of 2023 primarily resulting from an increase in B2B2C revenues and reflects a decrease of 18.5% compared to the first quarter of 2023 due to milestone driven revenues. Core revenue channel B2B2C, employers and health plans recurring revenues in the first quarter totaled $3.47 million , an increase of 176% year over year and 210%... Read More
Company to host conference call and webcast at 8:30am ET NEW YORK , May 7, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 1 st quarter ended March 31 st , 2024, on Wednesday, May 15 th , 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time. Erez... Read More
Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solution for members to manage diabetes, pre-diabetes, blood pressure, weight and taking a GLP-1 NEW YORK , April 25, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research published in the leading peer-reviewed journal for digital... Read More
Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health NEW YORK , April 18, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions for two employers beginning in the second quarter of 2024. The employers, a... Read More
Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens NEW YORK , April 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new studies published in the leading peer-reviewed journal for digital health and medicine, Journal of Internet Medicine (JMIR), including a... Read More
Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - musculoskeletal and behavioral health NEW YORK , April 2, 2024 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions... Read More
Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the core B2B2C revenue increased. 2023 B2B2C, employers and health plans recurring revenues increased 39% year over year as the core business continues to gain traction. Commercial revenues in 2023 generated majority of the revenue with B2B2C growing from 13% to 25% of... Read More
Company to host conference call and webcast at 8:30am ET NEW YORK , March 21, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 4 th quarter ended December 31, 2023, on Thursday, March 28 th , 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time. Erez... Read More
Study presented at ATTD 2024 is the first of a planned series examining the impact of Dario's integrated cardiometabolic solution as a means to address weight and diabetes with or without a GLP-1 Additional research presented demonstrated Dario's ability to improve awareness of the importance of flu vaccines in member with Type 2 diabetes NEW YORK , March 12, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the... Read More
NEW YORK , Feb. 28, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that management will participate in the Cowen 44 th Annual Healthcare Conference, which is being held March 4-6, 2024 , at the Boston Marriott Copley Place in Boston, Massachusetts . Erez Raphael , Chief Executive Officer, and Rick Anderson , President, will participate in a fireside chat... Read More
NEW YORK , Feb. 28, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that management will participate in the Cowen 44 th Annual Healthcare Conference, which is being held March 4-6, 2024 , at the Boston Marriott Copley Place in Boston, Massachusetts . Erez Raphael , Chief Executive Officer, and Rick Anderson , President, will participate in a fireside chat... Read More
Expecting nearly doubling Dario's pro forma revenues in 2023 Acquisition is immediately accretive to revenue and gross margins and expected to accelerate path to profitability Concurrent with the acquisition Dario prices $22.4 million equity financing Company to host conference call today at 8:30am ET . Dial-in and replay information below NEW YORK , Feb. 21, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or... Read More
Dario's integrated solution to support improved whole health gains traction in public and labor market NEW YORK , Jan. 11, 2024 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide its cardiometabolic solution to a regional union (the "Union"), expected to begin in the first quarter of 2024. The Union, representing... Read More
New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pre-diabetes, hypertension and those taking a GLP-1 medication NEW YORK , Dec. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide cardiometabolic and GLP-1 solutions to a national... Read More
Nonprofit health plan expands services to better meet the healthcare needs of Californians by making it easier to enroll in lifestyle medicine programs at no additional cost OAKLAND, Calif. , Nov. 29, 2023 /PRNewswire/ -- Blue Shield of California is making its award-winning digital health platform Wellvolution more accessible for Spanish-speakers and expanding its program with the addition of Dario, an at-home solution for... Read More
Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization search for proven ways to change health behaviors NEW YORK , Nov. 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide its cardiometabolic solution to an employer... Read More
Two new analyses associate improved clinical and economic outcomes with use of Dario's digital health solution NEW YORK , Nov. 21, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new analyses recently presented by Sanofi U.S. demonstrating two mediators associated with improved clinical and economic in Dario users. Improved... Read More
New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1s NEW YORK , Nov. 13, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research presented at the Diabetes Technology Society 2023 Meeting on November 7, 2023 . The new research demonstrated the value of associating... Read More
Third quarter total revenue of $3.52 million compared to $6.6 million in the third quarter of 2022, impacted mainly by lower commercial strategic partners revenues in the quarter of $209,000 as compared to $3.1 million in Q3 2022. Third quarter 2023 commercial B2B2C revenues from monthly recurring revenues derived from employers and health plans is up 19.3% over third quarter 2022; nine months YTD up 57% over comparable... Read More
New connectivity expands Dario's advantage with consumer accessibility NEW YORK , Nov. 1, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced the launch of a new smart blood sugar meter for Apple iPhone 15 users to support ongoing engagement with new and existing members. As recently reported, the new iPhone 15 is built with a USB-C... Read More
Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 30, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it will release its financial results for the third quarter ended September 30, 2023 , on Thursday, November 2, 2023 , before market opens and will host a conference call and webcast at 8:30 am Eastern Time . Erez Raphael , Chief... Read More
New research demonstrates Dario's ability to reduce costs through lower utilization of expensive healthcare resources, and the winning of a prestigious gold ribbon award NEW YORK , Oct. 17, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research presented by Sanofi U.S. at the Academy of Managed Care Pharmacy's 2023 annual... Read More
Agreement names Dario as the preferred digital health provider for employer clients NEW YORK , Oct. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced a new strategic partnership with a top five national employee benefits consulting firm (the "Firm"), to become the preferred digital health and chronic condition solution partner for its... Read More
In-person event scheduled for Tuesday, October 17, 2023 , in New York NEW YORK , Oct. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced that it will host an in-person investor day in New York at the offices of Sullivan & Worcester LLP located at 1633 Broadway, 32 nd floor, on October 17, 2023 at 11:00 AM ET . To attend the in-person... Read More
63% of members using the Dario platform saw significant reduction in depression and anxiety symptoms NEW YORK , Sept. 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research published in the Journal of Medical Internet Research (JMIR) demonstrating the impact of coaching and breathing exercises as part of the Dario digital... Read More
New research presented at ADCES23 links engagement in Dario's digital health solutions with improved outcomes NEW YORK , Aug. 24, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research presented at the ADCES23 Annual Conference held earlier this month in Houston, Texas . The new research demonstrates Dario's ability to sustainably... Read More
New agreement expands Dario's reach in the employer market with access to more than 5 million consumers NEW YORK , Aug. 15, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology, to offer integrated digital health solutions to... Read More
Generated sequential B2B recurring revenue growth for the tenth consecutive quarter Revenues of $6.15 million (pre-announced), compared to $6.18 million in the second quarter of 2022, a 0.5% decrease resulting from a delay with one of our strategic partners Improved gross profit margin to 33.7% of revenues for the second quarter of 2023, up from 18.4% for the second quarter of 2022 Improved proforma gross profit margin to... Read More
Dario to provide support for members living with diabetes alongside existing hypertension solution NEW YORK , Aug. 8, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today the expansion of its agreement with a large regional health plan (the "Plan") to deliver highly personalized digital health solutions to Plan members living with... Read More
Company to host conference call and webcast at 8:30am ET NEW YORK , Aug. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it will release its financial results for the second quarter ended June 30, 2023 , on Thursday, August 10, 2023 , before market opens and will host a conference call and webcast at 8:30 am Eastern Time . Erez Raphael , Chief... Read More
New program delivers whole health behavior change program to improve member health and deliver valuable insights to Dario's partners NEW YORK , Aug. 2, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced a new program today to deliver tailored behavior change support for individuals using GLP-1s and other anti-obesity drugs. The new program... Read More
Retrospective cohort study demonstrated significant reduction in medical costs for Dario users with Type 2 diabetes compared to non-users driven by a significant reduction in in-patient hospitalizations after one year NEW YORK , July 26, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new analysis by Sanofi US demonstrating a... Read More
New account is set to launch in July 2023 for eligible members NEW YORK , July 24, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new agreement with a large regional health plan (the "Plan") to deliver highly personalized digital health solutions to more than 160,000 Plan members living with hypertension. The Plan is set to... Read More
New account anticipated to contribute to revenue in the second half of 2023 NEW YORK , July 6, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a new employer contract for the Company's full suite of integrated solutions. The new account is scheduled to launch in the second half of 2023. The new account is an educational... Read More
Retrospective cohort study presented at the American Diabetes Association 83 rd Scientific Sessions analyzed real-world data of Dario users against matched controls to demonstrate a greater reduction when compared to non-users who achieve a 1.8 point reduction with the usual standard of care NEW YORK , June 26, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital... Read More
New accounts are anticipated to launch in the second half of 2023 NEW YORK , June 7, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new employer contracts for the Company's full suite of integrated solutions. The new accounts are scheduled to launch in the second half of 2023. Dario will deliver the full suite of integrated... Read More
NEW YORK , June 1, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that the Company will participate in the Stifel 2023 Virtual Cross Sector Insight Conference, which is being held June 6-7, 2023 , at The Intercontinental in Boston, MA. Rick Anderson , President of Dario, is scheduled to give a company presentation on Tuesday,... Read More
Dario's health solution now available to MedOne clients enrolled in Diabetes Care Path NEW YORK , May 18, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global health market, and MedOne Pharmacy Benefit Solutions ("PBM"), a national leader in modern pharmacy benefits management, announce a new agreement to integrate Dario's suite of digital health solutions as a complement... Read More
Sequential quarterly growth in revenue to $7.07 million Gross profit margin improving to 44.8% sequentially in the first quarter of 2023, up from 40.1% of revenues in the fourth quarter of 2022 Non-GAAP gross margin was 60.1% of revenues for the first quarter of 2023, up from 58.1% of revenues in the fourth quarter of 2022 Reduced cash used in operating activities in the first quarter to only $4.76 million Further reduced... Read More
Retrospective cohort study presented at ISPOR analyzed real-world data of users and non-users of a digital health solution NEW YORK , May 9, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today the presentation of research at ISPOR 2023 demonstrating significant reductions in healthcare resource utilization for Dario users compared to... Read More
Company to host conference call and webcast at 8:30am ET NEW YORK , May 4, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it would release its financial results for the first quarter ended March 31, 2023 , on Thursday, May 11, 2023 , before market opens and will host a conference call and webcast at 8:30 am Eastern Time . Erez Raphael , Chief... Read More
Newly designated convertible preferred stock priced at the market under Nasdaq rules with significant participation by select members of leadership, the Board and existing investors Company also announces refinancing of $25 million borrowed funds, saving approximately $6 million in annual amortization payments Proforma cash balance as of the end of Q1 inclusive of the private placement funds and the refinanced loan is $60M... Read More
Dario also appoints digital veteran, Arnaud Robert , to the role of Strategic Advisor to the Chief Executive Officer The appointments strengthen Dario's ability to scale its digital therapeutics platform to meet growing market demand NEW YORK , April 4, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company" or "Dario"), a leader in the global digital therapeutics (DTx) market, announced today that digital... Read More
New agreement is the first contract resulting from strategic partnership with Sanofi NEW YORK , March 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced a new contract with a leading nationwide Pharmacy Benefits Manager (the "PBM") operating in 50 states to provide Dario's digital therapeutics, starting with the diabetes... Read More
New agreement integrates Dario's cardiometabolic suite into Amwell's market leading digital care delivery enablement platform covering over 90 million lives NEW YORK , March 22, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today a strategic partnership with Amwell ® (NYSE: AMWL), a leader in digital healthcare enablement,... Read More
Dario's musculoskeletal solution uses data from a biofeedback sensor to drive healthier behaviors and reduce pain NEW YORK , March 14, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO)(the "Company" or "Dario"), a leader in the global digital therapeutics (DTx) market, announced today new research published in Pain Reports investigating personalized efficacy of digital therapeutics for pain management, linking the... Read More
Continued to improve the financial profile of the Company Full-year 2022 revenue of $27.7 million increased 34.8% over $20.5 million in 2021, as B2B revenue growth more than offset managed reduction of B2C activities Commercial revenue contributed 59% to 2022 full-year total revenue, compared to 4% for the full-year 2021 Gross margin was 40.1% of revenues for the fourth quarter of 2022, up from 9.1% of revenues for the... Read More
Company to host conference call and webcast at 8:30 am ET NEW YORK , March 2, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and year ended December 31, 2022 , on Thursday, March 9, 2023 , before market opens and will host a conference call and webcast at 8:30 am Eastern Time . Erez... Read More
Dario demonstrates the impact of targeted coaching interventions in a digital-first chronic care solution Dario solution demonstrates significant impact on hypoglycemic events in senior populations NEW YORK , Feb. 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today two new clinical studies presented at the 16 th International... Read More
NEW YORK , Feb. 24, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the Cowen 43 nd Annual Healthcare Conference, which is being held March 6-8, 2023 , at the Boston Marriott Copley Place in Boston, Massachusetts . Erez Raphael , Chief Executive Officer, and Rick Anderson , President, will participate in a... Read More
Mr. Kaplan brings a wealth of experience in business strategy specifically in healthcare and digital health NEW YORK , Feb. 23, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today the appointment of Jon Kaplan to serve as a board member effective immediately. Mr. Kaplan is a Managing Director and Senior Partner at Boston Consulting... Read More
New integration will improve access to Dario's multi-chronic platform for more people living with diabetes NEW YORK , Feb. 8, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today an agreement with Dexcom (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring (CGM) technology, to integrate its market-leading CGMs,... Read More
Preliminary Results demonstrate success in B2C to B2B transformation Total revenue for the year is expected to be $27.5 million compared to $20.5 million in 2021. B2B expected to represent approximately 60% of revenue in 2022 versus 4% in 2021 Continued improvement of Company's financial profile, reducing its operating loss by more than 50% compared to the fourth quarter of 2021. NEW YORK , Feb. 6, 2023 /PRNewswire/ --... Read More
Matt Alberico joins Dario to help manage expanding growth opportunities after successfully driving customer growth at Amazon Care, Cigna and Aetna NEW YORK , Jan. 24, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today the hire of seasoned industry sales leader Matt Alberico as Senior Vice President of Growth to help the Company... Read More
New York , Jan. 9, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today the publication of new research in the peer-reviewed journal Applied Sciences demonstrating improved outcomes for users living with diabetes across different racial and ethnic groups. The research appears in the journal as part of the Special Issue:... Read More
Northeast supermarket chain will deploy Dario's cardiometabolic suite in 2023 NEW YORK , Jan. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that a large Northeast U.S. supermarket chain (the "Employer") selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of... Read More
Transition to valued-based healthcare is driving consolidation in digital therapeutics. Dario’s clinically verified ROI to payors is lowering costs for the national healthcare sector. What is $162 billion in annual savings worth to the healthcare industry? DarioHealth Corp. (NASDAQ: DRIO) is adding contracts with self-insured employers and national health plans as Amazon and CVS vie to lead value-based, patient-centric... Read More
NEW YORK , Dec. 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced the publication of a new study in the peer-reviewed journal Frontiers in Physiology today demonstrating the effectiveness of the Company's musculoskeletal solution, which uses real-time biofeedback and behavior training to reduce back pain. Dario Move's posture... Read More
The new accounts originated through an existing relationship with a benefits brokerage and provide further validation of Dario's partnership Strategy. NEW YORK , Dec. 1, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that two employers selected Dario as part of an offering from a leading benefits brokerage partner that Dario had... Read More
Cue Biopharma

COPYRIGHT ©2023 HEALTH STOCKS HUB